Christopher Severson

1.5k total citations
13 papers, 778 citations indexed

About

Christopher Severson is a scholar working on Pathology and Forensic Medicine, Immunology and Neurology. According to data from OpenAlex, Christopher Severson has authored 13 papers receiving a total of 778 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 5 papers in Immunology and 2 papers in Neurology. Recurrent topics in Christopher Severson's work include Multiple Sclerosis Research Studies (7 papers), T-cell and B-cell Immunology (4 papers) and Immune Cell Function and Interaction (4 papers). Christopher Severson is often cited by papers focused on Multiple Sclerosis Research Studies (7 papers), T-cell and B-cell Immunology (4 papers) and Immune Cell Function and Interaction (4 papers). Christopher Severson collaborates with scholars based in United States, Switzerland and Germany. Christopher Severson's co-authors include Vincent A. Pieribone, George B. Richerson, Wengang Wang, David A. Hafler, Philip L. De Jager, Carolin Dohle, Brian C. Healy, Lisa M. Maier, Stefania Risso Bradley and David M. Kofler and has published in prestigious journals such as Nature Neuroscience, The Journal of Immunology and Neurology.

In The Last Decade

Christopher Severson

13 papers receiving 762 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Severson United States 10 272 210 176 130 122 13 778
Adil Javed United States 18 171 0.6× 47 0.2× 479 2.7× 24 0.2× 51 0.4× 45 1.0k
Betty Y. Poon Canada 10 118 0.4× 285 1.4× 39 0.2× 110 0.8× 17 0.1× 12 583
Robert T. Geertman United States 15 108 0.4× 114 0.5× 318 1.8× 19 0.1× 34 0.3× 27 934
Zachary T. Resch United States 21 44 0.2× 371 1.8× 30 0.2× 278 2.1× 70 0.6× 33 1.3k
Jorge G. Arroyo United States 22 38 0.1× 207 1.0× 28 0.2× 106 0.8× 59 0.5× 101 1.5k
Ronald L. Wilder United States 14 282 1.0× 49 0.2× 45 0.3× 18 0.1× 105 0.9× 21 966
Clara de Andrés Spain 22 502 1.8× 46 0.2× 575 3.3× 84 0.6× 95 0.8× 61 1.4k
Jenny Fjell United States 15 389 1.4× 29 0.1× 244 1.4× 37 0.3× 40 0.3× 16 1.7k
Wouter Beumer Netherlands 8 270 1.0× 26 0.1× 48 0.3× 26 0.2× 110 0.9× 9 1.1k

Countries citing papers authored by Christopher Severson

Since Specialization
Citations

This map shows the geographic impact of Christopher Severson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Severson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Severson more than expected).

Fields of papers citing papers by Christopher Severson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Severson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Severson. The network helps show where Christopher Severson may publish in the future.

Co-authorship network of co-authors of Christopher Severson

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Severson. A scholar is included among the top collaborators of Christopher Severson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Severson. Christopher Severson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Houtchens, Maria K., Eric C. Klawiter, Andrew Solomon, et al.. (2025). A Real-World Prospective Multiple Sclerosis Pregnancy Registry in the United States. Neurology Clinical Practice. 15(2). e200425–e200425. 1 indexed citations
2.
Healy, Brian C., Jonathan Zurawski, Christopher Severson, et al.. (2022). COVID-19 severity is associated with worsened neurological outcomes in multiple sclerosis and related disorders. Multiple Sclerosis and Related Disorders. 63. 103946–103946. 25 indexed citations
3.
Holroyd, Kathryn B., Brian C. Healy, Maria K. Houtchens, et al.. (2022). Humoral response to COVID-19 vaccination in MS patients on disease modifying therapy: Immune profiles and clinical outcomes. Multiple Sclerosis and Related Disorders. 67. 104079–104079. 17 indexed citations
4.
Singhal, Tarun, Kelsey Carter, Eero Rissanen, et al.. (2022). Efficacy of Ofatumumab on Microglial Activity in Patients with Relapsing forms of Multiple Sclerosis: Interim Analysis (S14.008). Neurology. 98(18_supplement). 1 indexed citations
5.
Klawiter, Eric C., Andrew Solomon, Ellen Lathi, et al.. (2020). Prospective growth and developmental outcomes in infants born to mothers with multiple sclerosis. Multiple Sclerosis Journal. 27(1). 79–89. 5 indexed citations
6.
Kim, Gloria, Renxin Chu, Shahamat Tauhid, et al.. (2017). Sample size requirements for one-year treatment effects using deep gray matter volume from 3T MRI in progressive forms of multiple sclerosis. International Journal of Neuroscience. 127(11). 971–980. 11 indexed citations
7.
Bakshi, Rohit, Mohit Neema, Shahamat Tauhid, et al.. (2014). An expanded composite scale of MRI-defined disease severity in multiple sclerosis. Neuroreport. 25(14). 1156–1161. 20 indexed citations
8.
Kofler, David M., et al.. (2011). The CD6 Multiple Sclerosis Susceptibility Allele Is Associated with Alterations in CD4+ T Cell Proliferation. The Journal of Immunology. 187(6). 3286–3291. 67 indexed citations
9.
Maier, Lisa M., David E. Anderson, Christopher Severson, et al.. (2009). Soluble IL-2RA Levels in Multiple Sclerosis Subjects and the Effect of Soluble IL-2RA on Immune Responses. The Journal of Immunology. 182(3). 1541–1547. 121 indexed citations
10.
Maier, Lisa M., Christopher E. Lowe, Jason D. Cooper, et al.. (2009). IL2RA Genetic Heterogeneity in Multiple Sclerosis and Type 1 Diabetes Susceptibility and Soluble Interleukin-2 Receptor Production. PLoS Genetics. 5(1). e1000322–e1000322. 186 indexed citations
11.
Severson, Christopher & David A. Hafler. (2009). T-Cells in Multiple Sclerosis. Results and problems in cell differentiation. 51. 75–98. 34 indexed citations
12.
Severson, Christopher, Wengang Wang, Vincent A. Pieribone, Carolin Dohle, & George B. Richerson. (2003). Midbrain serotonergic neurons are central pH chemoreceptors. Nature Neuroscience. 6(11). 1139–1140. 165 indexed citations
13.
Bradley, Stefania Risso, et al.. (2002). Chemosensitive serotonergic neurons are closely associated with large medullary arteries. Nature Neuroscience. 5(5). 401–402. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026